Citius Pharmaceuticals Inc. Common (CTXR) is a publicly traded Healthcare sector company. As of May 21, 2026, CTXR trades at $0.57 with a market cap of $14.47M and a P/E ratio of -0.26. CTXR moved +4.31% today. Year to date, CTXR is -38.29%; over the trailing twelve months it is -21.47%. Its 52-week range spans $0.48 to $13.52. Rallies surfaces CTXR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Citius Pharmaceuticals Inc. Common (CTXR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CTXR moved +4.31% today.
| Metric | Value |
|---|---|
| Price | $0.57 |
| Market Cap | $14.47M |
| P/E Ratio | -0.26 |
| EPS | $-2.24 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.52 |
| 52-Week Low | $0.48 |
| Volume | 892.61K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.61M |
| Net Income | $-55.45M |
| Gross Margin | 0.00% |
CTXR analyst coverage data. Average price target: $0.00.